Product Administered At Inappropriate Site
10 drugs973 FAERS reportsMedDRA PT
GET
/api/v1/reaction/product-administered-at-inappropriate-siteReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Product Administered At Inappropriate Site (10)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Zinc Pyrithione114%
- 2Aluminum Chlorohydrate513%
- 3Aluminum Zirconium Tetrachlorohydrex Gly24.8%
- 4Aripiprazole Lauroxil2064.6%
- 5Butenafine132.3%
- 6Thyrotropin202.0%
- 7Thyrotropin Alfa202.0%
- 8Lenacapavir71.7%
- 9Delgocitinib31.7%
- 10Minoxidil6961.6%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Drug Administered At Inappropriate Site3 shared · 0.30
- Product Formulation Issue3 shared · 0.23
- Blood Thyroid Stimulating Hormone Decreased2 shared · 0.20
- Oropharyngeal Pain3 shared · 0.09
- Application Site Irritation2 shared · 0.09
- Application Site Rash2 shared · 0.09
- Application Site Pain4 shared · 0.08
- Expired Product Administered2 shared · 0.08
- Injection Site Mass2 shared · 0.08
- Inappropriate Schedule Of Drug Administration2 shared · 0.07
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.